Hydrochloric Acid

Hydrochloric Acid

SCHEMBL45756

CCCCCC(O)C[N+](C)(C)CC(O)CCCCC.[Cl-]

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PSMD14 O00487 2/20 0.69
PLA2G1B P04054 2/20 0.69
MMP2 P08253 2/20 0.69
ATG4B Q9Y4P1 2/20 0.69
HSP90AA1 P07900 1/20 0.69
RAD52 P43351 1/20 0.63
GPR84 Q9NQS5 8/20 0.52
FFAR1 O14842 2/20 0.50
FFAR4 Q5NUL3 1/20 0.50
NFKB1 P19838 1/20 0.48
FDPS P14324 3/20 0.41
TRPA1 O75762 1/20 0.41
DDAH1 O94760 1/20 0.41
GAPDH P04406 1/20 0.41
MAPT P10636 1/20 0.41
FAAH O00519 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8040639 1.00 PSMD14 (0.69) PSMD14PLA2G1BMMP2ATG4BHSP90AA1
Hydrochloric Acid SCHEMBL2912562 0.98 PSMD14 (0.72) PSMD14PLA2G1BMMP2ATG4BHSP90AA1
Hydrochloric Acid SCHEMBL11227182 0.98 PSMD14 (0.72) PSMD14PLA2G1BMMP2ATG4BHSP90AA1
Hydrochloric Acid SCHEMBL11215399 0.98 PSMD14 (0.72) PSMD14PLA2G1BMMP2ATG4BHSP90AA1
Hydrochloric Acid SCHEMBL11875761 0.98 PSMD14 (0.72) PSMD14PLA2G1BMMP2ATG4BHSP90AA1
Hydrochloric Acid SCHEMBL11595988 0.90 PLA2G1B (0.74) PSMD14PLA2G1BMMP2ATG4BHSP90AA1
Hydrochloric Acid SCHEMBL11527519 0.90 PLA2G1B (0.74) PSMD14PLA2G1BMMP2ATG4BHSP90AA1
Hydrochloric Acid SCHEMBL11596806 0.90 PLA2G1B (0.74) PSMD14PLA2G1BMMP2ATG4BHSP90AA1
Hydrochloric Acid SCHEMBL27937629 0.90 PLA2G1B (0.74) PSMD14PLA2G1BMMP2ATG4BHSP90AA1
Hydrochloric Acid SCHEMBL28668483 0.90 PLA2G1B (0.74) PSMD14PLA2G1BMMP2ATG4BHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 398 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240052276-A9 FLEXIBLE, POROUS, DISSOLVABLE SOLID SHEET ARTICLES CONTAINING CATIONIC SURFACTANT THE PROCTER AND GAMBLE COMPANY 2024-02-15 US claimed
US-20110281785-A1 FABRIC ENHANCERS COMPRISING NANO-SIZED LAMELLAR VESICLE GIZAW YONAS (US) 2011-11-17 US claimed
US-7928055-B2 Clear and/or translucent fabric enhancers comprising nano-sized particles THE PROCTER & GAMBLE COMPANY (US) 2011-04-19 US claimed
EP-2049640-A2 CLEAR AND/OR TRANSLUCENT FABRIC ENHANCERS COMPRISING NANO-SIZED PARTICLES The Procter and Gamble Company (US) 2009-04-22 EP claimed
EP-2049639-A1 FABRIC ENHANCERS COMPRISING NANO-SIZED LAMELLAR VESICLE The Procter and Gamble Company (US) 2009-04-22 EP claimed
US-20090042767-A1 Clear and/or translucent fabric enhancers comprising nano-sized particles THE PROCTER & GAMBLE COMPANY 2009-02-12 US claimed
US-20090042765-A1 Fabric enhancers comprising nano-sized lamellar vesicle PROCTER & GAMBLE COMPANY, THE 2009-02-12 US claimed
US-20080263780-A1 Fabric enhancing compositions comprising nano-sized particles and anionic detergent carry over tollerance THE PROCTER & GAMBLE COMPANY 2008-10-30 US claimed
WO-2008021893-A1 FABRIC ENHANCING COMPOSITIONS COMPRISING NANO-SIZED PARTICLES AND ANIONIC DETERGENT CARRY OVER TOLLERANCE THE PROCTER & GAMBLE COMPANY (US) 2008-02-21 WO claimed
WO-2008021895-A2 CLEAR AND/OR TRANSLUCENT FABRIC ENHANCERS COMPRISING NANO-SIZED PARTICLES THE PROCTER & GAMBLE COMPANY (US) 2008-02-21 WO claimed
WO-2008021892-A1 FABRIC ENHANCERS COMPRISING NANO-SIZED LAMELLAR VESICLE THE PROCTER & GAMBLE COMPANY (US) 2008-02-21 WO claimed
EP-4399269-A1 PHENOLIC COMPOSITIONS FOR MALODOR REDUCTION Milliken & Company (US) 2024-07-17 EP disclosed
US-12031113-B2 Composition comprising hueing agent MILLIKEN & COMPANY (US) 2024-07-09 US disclosed
US-12018232-B2 Multilayer dissolvable solid article containing solid particles for making the same THE PROCTER & GAMBLE COMPANY (US) 2024-06-25 US disclosed
US-20240197579-A9 MULTILAYER DISSOLVABLE SOLID ARTICLE CONTAINING COATING COMPOSITION AND PROCESS FOR MAKING THE SAME THE PROCTER AND GAMBLE COMPANY 2024-06-20 US disclosed
WO-1998008924-A2 CONCENTRATED PREMIX WITH REDUCED FLAMMABILITY FOR FORMING FABRIC SOFTENING COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1998-03-05 WO disclosed
WO-1998003619-A1 CONCENTRATED FABRIC SOFTENING COMPOSITION AND HIGHLY UNSATURATED FABRIC SOFTENER COMPOUND THEREFOR THE PROCTER & GAMBLE COMPANY (US) 1998-01-29 WO disclosed
WO-1997034976-A1 CONCENTRATED, STABLE, PREMIX FOR FORMING FABRIC SOFTENING COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1997-09-25 WO disclosed
WO-1997034975-A1 CONCENTRATED FABRIC SOFTENING COMPOSITION WITH GOOD FREEZE/THAW RECOVERY AND HIGHLY UNSATURATED FABRIC SOFTENER COMPOUND THEREFOR THE PROCTER & GAMBLE COMPANY (US) 1997-09-25 WO disclosed
WO-1997003170-A1 CONCENTRATED, WATER DISPERSIBLE, STABLE, FABRIC SOFTENING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-01-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240197579-A9 MULTILAYER DISSOLVABLE SOLID ARTICLE CONTAINING COATING COMPOSITION AND PROCESS FOR MAKING THE SAME SEPTIN8, DSTN, SEPTIN2 PSMD14 463/4885PLA2G1B 2015/4885MMP2 1029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.